Structure

Physi-Chem Properties

Molecular Weight:  698.24
Volume:  709.537
LogP:  4.612
LogD:  4.016
LogS:  -3.497
# Rotatable Bonds:  18
TPSA:  170.44
# H-Bond Aceptor:  12
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.082
Synthetic Accessibility Score:  3.902
Fsp3:  0.179
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.107
MDCK Permeability:  1.762491956469603e-05
Pgp-inhibitor:  0.851
Pgp-substrate:  0.338
Human Intestinal Absorption (HIA):  0.36
20% Bioavailability (F20%):  0.993
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.036
Plasma Protein Binding (PPB):  101.74585723876953%
Volume Distribution (VD):  0.366
Pgp-substrate:  1.5738766193389893%

ADMET: Metabolism

CYP1A2-inhibitor:  0.145
CYP1A2-substrate:  0.641
CYP2C19-inhibitor:  0.866
CYP2C19-substrate:  0.068
CYP2C9-inhibitor:  0.898
CYP2C9-substrate:  0.981
CYP2D6-inhibitor:  0.397
CYP2D6-substrate:  0.918
CYP3A4-inhibitor:  0.823
CYP3A4-substrate:  0.853

ADMET: Excretion

Clearance (CL):  7.324
Half-life (T1/2):  0.918

ADMET: Toxicity

hERG Blockers:  0.456
Human Hepatotoxicity (H-HT):  0.064
Drug-inuced Liver Injury (DILI):  0.039
AMES Toxicity:  0.363
Rat Oral Acute Toxicity:  0.055
Maximum Recommended Daily Dose:  0.848
Skin Sensitization:  0.972
Carcinogencity:  0.256
Eye Corrosion:  0.003
Eye Irritation:  0.037
Respiratory Toxicity:  0.036

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC475250

Natural Product ID:  NPC475250
Common Name*:   Dadahol A
IUPAC Name:   [(E)-3-[4-[1-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxypropan-2-yl]oxy-3,5-dimethoxyphenyl]prop-2-enyl] (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms:  
Standard InCHIKey:  IKHAPHPJWABCCU-WGSZPKJISA-N
Standard InCHI:  InChI=1S/C39H38O12/c1-46-32-23-28(12-17-31(32)42)38(45)35(24-50-37(44)19-11-26-8-15-30(41)16-9-26)51-39-33(47-2)21-27(22-34(39)48-3)5-4-20-49-36(43)18-10-25-6-13-29(40)14-7-25/h4-19,21-23,35,38,40-42,45H,20,24H2,1-3H3/b5-4+,18-10+,19-11+
SMILES:  COC1=CC(=CC(=C1OC(COC(=O)C=CC2=CC=C(C=C2)O)C(C3=CC(=C(C=C3)O)OC)O)OC)C=CCOC(=O)C=CC4=CC=C(C=C4)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL501943
PubChem CID:   10908643
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0001392] Lignans, neolignans and related compounds

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO10498 Artocarpus dadah Species Moraceae Eukaryota bark and twigs Tewah, Central Kalimantan, Indonesia (N 38 57.003; W 094 44.767) 1999-Oct PMID[11858749]
NPO10498 Artocarpus dadah Species Moraceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO10498 Artocarpus dadah Species Moraceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10498 Artocarpus dadah Species Moraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT30 Individual Protein Cyclooxygenase-1 Homo sapiens IC50 > 100.0 ug.mL-1 PMID[463147]
NPT31 Individual Protein Cyclooxygenase-2 Homo sapiens IC50 > 100.0 ug.mL-1 PMID[463147]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC475250 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9716 High Similarity NPC473909
0.9716 High Similarity NPC274960
0.9716 High Similarity NPC143120
0.9338 High Similarity NPC476373
0.9333 High Similarity NPC125495
0.9247 High Similarity NPC102934
0.9247 High Similarity NPC476348
0.9247 High Similarity NPC252402
0.9247 High Similarity NPC187398
0.9241 High Similarity NPC268515
0.9241 High Similarity NPC40222
0.9216 High Similarity NPC476372
0.9216 High Similarity NPC476371
0.9184 High Similarity NPC106138
0.9178 High Similarity NPC476347
0.9149 High Similarity NPC471719
0.9128 High Similarity NPC163598
0.9128 High Similarity NPC120774
0.9128 High Similarity NPC264875
0.9122 High Similarity NPC120426
0.9122 High Similarity NPC294522
0.9122 High Similarity NPC205727
0.9122 High Similarity NPC21184
0.9097 High Similarity NPC193722
0.9097 High Similarity NPC278469
0.9091 High Similarity NPC267291
0.9085 High Similarity NPC126206
0.9085 High Similarity NPC474390
0.9079 High Similarity NPC470827
0.9067 High Similarity NPC115203
0.9054 High Similarity NPC176903
0.9054 High Similarity NPC30688
0.9038 High Similarity NPC59516
0.9028 High Similarity NPC83375
0.9028 High Similarity NPC224876
0.902 High Similarity NPC470828
0.9014 High Similarity NPC471664
0.9014 High Similarity NPC471665
0.9007 High Similarity NPC309744
0.9007 High Similarity NPC469888
0.9007 High Similarity NPC135127
0.9 High Similarity NPC472612
0.9 High Similarity NPC289967
0.9 High Similarity NPC472611
0.8958 High Similarity NPC106055
0.8958 High Similarity NPC291101
0.8958 High Similarity NPC266197
0.8958 High Similarity NPC262189
0.8958 High Similarity NPC110699
0.8958 High Similarity NPC22317
0.894 High Similarity NPC475141
0.8926 High Similarity NPC470826
0.8926 High Similarity NPC473266
0.8926 High Similarity NPC470098
0.8919 High Similarity NPC15577
0.8889 High Similarity NPC22517
0.8882 High Similarity NPC473736
0.8873 High Similarity NPC170694
0.8873 High Similarity NPC111635
0.8867 High Similarity NPC477612
0.8865 High Similarity NPC16208
0.8865 High Similarity NPC35932
0.8865 High Similarity NPC184447
0.8865 High Similarity NPC160991
0.8865 High Similarity NPC7903
0.8859 High Similarity NPC281549
0.8859 High Similarity NPC478237
0.8846 High Similarity NPC12326
0.8844 High Similarity NPC28440
0.8844 High Similarity NPC171932
0.8836 High Similarity NPC67467
0.8816 High Similarity NPC470769
0.8816 High Similarity NPC150442
0.8808 High Similarity NPC7145
0.8808 High Similarity NPC125823
0.8808 High Similarity NPC85192
0.8808 High Similarity NPC143480
0.8808 High Similarity NPC329343
0.8808 High Similarity NPC321972
0.8808 High Similarity NPC324517
0.88 High Similarity NPC283839
0.88 High Similarity NPC90896
0.8794 High Similarity NPC470096
0.8794 High Similarity NPC469625
0.8794 High Similarity NPC469613
0.8794 High Similarity NPC30043
0.8794 High Similarity NPC470095
0.8794 High Similarity NPC472597
0.8784 High Similarity NPC252292
0.8784 High Similarity NPC34927
0.8784 High Similarity NPC100998
0.8784 High Similarity NPC34587
0.8784 High Similarity NPC476382
0.8782 High Similarity NPC149873
0.8782 High Similarity NPC7191
0.8776 High Similarity NPC478239
0.8767 High Similarity NPC470372
0.8766 High Similarity NPC11411
0.8766 High Similarity NPC473275
0.8766 High Similarity NPC470896
0.8758 High Similarity NPC476374
0.8758 High Similarity NPC8712
0.875 High Similarity NPC169404
0.875 High Similarity NPC53587
0.875 High Similarity NPC476434
0.875 High Similarity NPC476365
0.875 High Similarity NPC478268
0.875 High Similarity NPC176186
0.875 High Similarity NPC180768
0.875 High Similarity NPC120852
0.875 High Similarity NPC75695
0.8742 High Similarity NPC476871
0.8741 High Similarity NPC249791
0.8741 High Similarity NPC237594
0.8741 High Similarity NPC119060
0.8741 High Similarity NPC310854
0.8741 High Similarity NPC476387
0.8733 High Similarity NPC28651
0.8733 High Similarity NPC300262
0.8733 High Similarity NPC192763
0.8733 High Similarity NPC80732
0.8733 High Similarity NPC210611
0.8733 High Similarity NPC199311
0.8733 High Similarity NPC261122
0.8733 High Similarity NPC93924
0.8733 High Similarity NPC201148
0.8733 High Similarity NPC215095
0.8733 High Similarity NPC3460
0.8732 High Similarity NPC131128
0.8732 High Similarity NPC5423
0.8732 High Similarity NPC245120
0.8732 High Similarity NPC474134
0.8732 High Similarity NPC470752
0.8725 High Similarity NPC476865
0.8725 High Similarity NPC199928
0.8723 High Similarity NPC472338
0.8723 High Similarity NPC469612
0.8723 High Similarity NPC307042
0.8723 High Similarity NPC79184
0.8723 High Similarity NPC469614
0.8718 High Similarity NPC53889
0.8716 High Similarity NPC470097
0.8716 High Similarity NPC471415
0.8716 High Similarity NPC114119
0.8707 High Similarity NPC157816
0.8707 High Similarity NPC469559
0.8707 High Similarity NPC140502
0.8696 High Similarity NPC476370
0.8693 High Similarity NPC149735
0.8693 High Similarity NPC146277
0.8693 High Similarity NPC474656
0.8693 High Similarity NPC19380
0.8684 High Similarity NPC300329
0.8681 High Similarity NPC214729
0.8675 High Similarity NPC94871
0.8675 High Similarity NPC470933
0.8675 High Similarity NPC471062
0.8675 High Similarity NPC473427
0.8675 High Similarity NPC306890
0.8675 High Similarity NPC318373
0.8675 High Similarity NPC211561
0.8675 High Similarity NPC321657
0.8675 High Similarity NPC259347
0.8675 High Similarity NPC476386
0.8675 High Similarity NPC476398
0.8671 High Similarity NPC36490
0.8667 High Similarity NPC328567
0.8667 High Similarity NPC320671
0.8667 High Similarity NPC232992
0.8667 High Similarity NPC178129
0.8667 High Similarity NPC327412
0.8667 High Similarity NPC320970
0.8662 High Similarity NPC309787
0.8658 High Similarity NPC476868
0.8658 High Similarity NPC476864
0.8658 High Similarity NPC476869
0.8658 High Similarity NPC476866
0.8654 High Similarity NPC87317
0.8654 High Similarity NPC478269
0.8652 High Similarity NPC470258
0.8652 High Similarity NPC190629
0.8652 High Similarity NPC202582
0.8652 High Similarity NPC48315
0.8652 High Similarity NPC226788
0.8652 High Similarity NPC222004
0.8652 High Similarity NPC210623
0.8652 High Similarity NPC273295
0.8652 High Similarity NPC83062
0.8652 High Similarity NPC285339
0.8652 High Similarity NPC3439
0.8652 High Similarity NPC218856
0.8649 High Similarity NPC110067
0.8649 High Similarity NPC91492
0.8649 High Similarity NPC34245
0.8649 High Similarity NPC7439
0.8649 High Similarity NPC256555
0.8639 High Similarity NPC186406
0.8639 High Similarity NPC178054
0.8636 High Similarity NPC268484
0.863 High Similarity NPC55947

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC475250 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8526 High Similarity NPD4868 Clinical (unspecified phase)
0.8521 High Similarity NPD3027 Phase 3
0.8431 Intermediate Similarity NPD1653 Approved
0.8378 Intermediate Similarity NPD7266 Discontinued
0.8354 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8345 Intermediate Similarity NPD1613 Approved
0.8345 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.816 Intermediate Similarity NPD6166 Phase 2
0.8069 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD5844 Phase 1
0.8012 Intermediate Similarity NPD7054 Approved
0.8 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD1934 Approved
0.7964 Intermediate Similarity NPD7472 Approved
0.7964 Intermediate Similarity NPD7074 Phase 3
0.7922 Intermediate Similarity NPD6190 Approved
0.7888 Intermediate Similarity NPD3817 Phase 2
0.7853 Intermediate Similarity NPD6234 Discontinued
0.7844 Intermediate Similarity NPD7228 Approved
0.7844 Intermediate Similarity NPD3818 Discontinued
0.784 Intermediate Similarity NPD7768 Phase 2
0.7826 Intermediate Similarity NPD2801 Approved
0.7826 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7824 Intermediate Similarity NPD7808 Phase 3
0.7823 Intermediate Similarity NPD4908 Phase 1
0.7765 Intermediate Similarity NPD7251 Discontinued
0.7764 Intermediate Similarity NPD37 Approved
0.7758 Intermediate Similarity NPD7199 Phase 2
0.7758 Intermediate Similarity NPD8127 Discontinued
0.773 Intermediate Similarity NPD3882 Suspended
0.773 Intermediate Similarity NPD4967 Phase 2
0.773 Intermediate Similarity NPD4966 Approved
0.773 Intermediate Similarity NPD4965 Approved
0.7724 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7718 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD1465 Phase 2
0.7706 Intermediate Similarity NPD6797 Phase 2
0.7683 Intermediate Similarity NPD7075 Discontinued
0.7677 Intermediate Similarity NPD1652 Phase 2
0.7673 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD5402 Approved
0.7616 Intermediate Similarity NPD7549 Discontinued
0.7607 Intermediate Similarity NPD8455 Phase 2
0.7605 Intermediate Similarity NPD6232 Discontinued
0.76 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7595 Intermediate Similarity NPD1511 Approved
0.7595 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD422 Phase 1
0.7576 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7574 Intermediate Similarity NPD7473 Discontinued
0.7566 Intermediate Similarity NPD5124 Phase 1
0.7566 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD230 Phase 1
0.7562 Intermediate Similarity NPD5403 Approved
0.756 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD7685 Pre-registration
0.7557 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD6233 Phase 2
0.7531 Intermediate Similarity NPD4380 Phase 2
0.7516 Intermediate Similarity NPD4628 Phase 3
0.7515 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7819 Suspended
0.75 Intermediate Similarity NPD1512 Approved
0.7485 Intermediate Similarity NPD7411 Suspended
0.7483 Intermediate Similarity NPD2982 Phase 2
0.7483 Intermediate Similarity NPD2983 Phase 2
0.7457 Intermediate Similarity NPD6559 Discontinued
0.7455 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD6801 Discontinued
0.7438 Intermediate Similarity NPD5401 Approved
0.7431 Intermediate Similarity NPD1548 Phase 1
0.7417 Intermediate Similarity NPD7095 Approved
0.7415 Intermediate Similarity NPD2981 Phase 2
0.7405 Intermediate Similarity NPD3750 Approved
0.7405 Intermediate Similarity NPD8166 Discontinued
0.74 Intermediate Similarity NPD3018 Phase 2
0.7386 Intermediate Similarity NPD4060 Phase 1
0.7384 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD6799 Approved
0.7371 Intermediate Similarity NPD8313 Approved
0.7371 Intermediate Similarity NPD8312 Approved
0.7368 Intermediate Similarity NPD6798 Discontinued
0.7356 Intermediate Similarity NPD7240 Approved
0.7355 Intermediate Similarity NPD7097 Phase 1
0.7347 Intermediate Similarity NPD1610 Phase 2
0.7342 Intermediate Similarity NPD6674 Discontinued
0.7338 Intermediate Similarity NPD4340 Discontinued
0.7337 Intermediate Similarity NPD6959 Discontinued
0.7305 Intermediate Similarity NPD228 Approved
0.7296 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD5494 Approved
0.7267 Intermediate Similarity NPD4357 Discontinued
0.7257 Intermediate Similarity NPD7039 Approved
0.7257 Intermediate Similarity NPD7038 Approved
0.7254 Intermediate Similarity NPD7843 Approved
0.7241 Intermediate Similarity NPD5536 Phase 2
0.7233 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD8053 Approved
0.7232 Intermediate Similarity NPD8054 Approved
0.7222 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7195 Intermediate Similarity NPD3686 Approved
0.7195 Intermediate Similarity NPD3687 Approved
0.7179 Intermediate Similarity NPD6653 Approved
0.7178 Intermediate Similarity NPD7314 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7171 Intermediate Similarity NPD2861 Phase 2
0.717 Intermediate Similarity NPD1549 Phase 2
0.7166 Intermediate Similarity NPD7680 Approved
0.7162 Intermediate Similarity NPD3496 Discontinued
0.7161 Intermediate Similarity NPD3620 Phase 2
0.7161 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7161 Intermediate Similarity NPD1558 Phase 1
0.716 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD6971 Discontinued
0.7152 Intermediate Similarity NPD1551 Phase 2
0.7143 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD5535 Approved
0.7126 Intermediate Similarity NPD3751 Discontinued
0.7117 Intermediate Similarity NPD7447 Phase 1
0.7117 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD6355 Discontinued
0.7115 Intermediate Similarity NPD447 Suspended
0.7114 Intermediate Similarity NPD1091 Approved
0.7108 Intermediate Similarity NPD4675 Approved
0.7108 Intermediate Similarity NPD6599 Discontinued
0.7108 Intermediate Similarity NPD4678 Approved
0.7107 Intermediate Similarity NPD5762 Approved
0.7107 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD5763 Approved
0.7103 Intermediate Similarity NPD7157 Approved
0.7093 Intermediate Similarity NPD3787 Discontinued
0.7089 Intermediate Similarity NPD3748 Approved
0.7088 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD3225 Approved
0.7083 Intermediate Similarity NPD5283 Phase 1
0.7081 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD4110 Phase 3
0.7078 Intermediate Similarity NPD4625 Phase 3
0.7073 Intermediate Similarity NPD6273 Approved
0.7066 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD3749 Approved
0.7055 Intermediate Similarity NPD7212 Phase 2
0.7055 Intermediate Similarity NPD7213 Phase 3
0.7051 Intermediate Similarity NPD4140 Approved
0.7048 Intermediate Similarity NPD8158 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7048 Intermediate Similarity NPD6055 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD2935 Discontinued
0.7044 Intermediate Similarity NPD2796 Approved
0.7043 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD5353 Approved
0.7039 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD4536 Approved
0.7025 Intermediate Similarity NPD4538 Approved
0.7025 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD1358 Approved
0.702 Intermediate Similarity NPD4749 Approved
0.7019 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD7446 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3705 Approved
0.6994 Remote Similarity NPD7229 Phase 3
0.6993 Remote Similarity NPD6584 Phase 3
0.6987 Remote Similarity NPD4062 Phase 3
0.6981 Remote Similarity NPD1510 Phase 2
0.6981 Remote Similarity NPD7033 Discontinued
0.698 Remote Similarity NPD6516 Phase 2
0.698 Remote Similarity NPD5846 Approved
0.6974 Remote Similarity NPD8651 Approved
0.6972 Remote Similarity NPD2684 Approved
0.6964 Remote Similarity NPD6386 Approved
0.6964 Remote Similarity NPD6385 Approved
0.6957 Remote Similarity NPD970 Clinical (unspecified phase)
0.6954 Remote Similarity NPD5242 Approved
0.6948 Remote Similarity NPD9494 Approved
0.6933 Remote Similarity NPD5307 Clinical (unspecified phase)
0.6928 Remote Similarity NPD2797 Approved
0.6923 Remote Similarity NPD6841 Approved
0.6923 Remote Similarity NPD6843 Phase 3
0.6923 Remote Similarity NPD7945 Clinical (unspecified phase)
0.6923 Remote Similarity NPD6842 Approved
0.6919 Remote Similarity NPD919 Approved
0.6914 Remote Similarity NPD3060 Approved
0.6913 Remote Similarity NPD1357 Approved
0.6909 Remote Similarity NPD3536 Discontinued
0.6903 Remote Similarity NPD6832 Phase 2
0.6899 Remote Similarity NPD1933 Approved
0.6899 Remote Similarity NPD5735 Approved
0.6894 Remote Similarity NPD3540 Phase 1
0.6893 Remote Similarity NPD8156 Discontinued
0.6891 Remote Similarity NPD8151 Discontinued
0.689 Remote Similarity NPD7440 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data